Pharmaceuticals, Biotechnology and Life Sciences
French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.
Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…
U.S. Court of Appeals for the Federal Circuit has upheld the district court’s decision and ruled in the Eli Lilly’s favor regarding validity and infringement of the vitamin regimen patent for Alimta (pemetrexed for injection).
Eli Lilly and Merck have expand an existing immuno-oncology collaboration through a subsidiary to add a new study of Lilly’s…
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
Eli Lilly’s subsidiary Elanco US has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) U.S. feline, canine and rabies vaccines…
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
The American Diabetes Association (ADA) has included new recommendation about the use of Jardiance tablets for type 2 diabetes patients…
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Eli Lilly and Boehringer Ingelheim Pharmaceuticals have announced that Basaglar (insulin glargine injection 100 units/mL) is available by prescription in…